A direct comparison of four agents as monotherapy in drug-naive patients with type 2 diabetes shows that exenatide once-weekly, metformin, and pioglitazone provide good improvement in glycemic control, while sitagliptin is less effective.…
Read More »Should Metformin Be Used for Type 1 Diabetes?
The addition of off-label metformin to insulin therapy to improve insulin sensitivity, promote weight control, and reduce insulin dose requirements in patients with type 1 diabetes, has been assessed in systematic reviews.…
Read More »A Decade Later, Lifestyle Changes or Metformin Still Lower Type 2 Diabetes Risk
Study reports on persistence of benefits seen in the Diabetes Prevention Program
Read More »